We are live on ! Find out more
ROSG

Rosetta Genomics
ROSG

Delisted

ROSG was delisted on the 21st of May, 2018.

8 hedge funds and large institutions have $552K invested in Rosetta Genomics in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

638% more capital inflows, than outflows

Capital inflows: $465K | Capital outflows: $63K

14.26% more ownership

Funds ownership: 8.5% → 22.76% (+14%)

20% less funds holding

Funds holding: 10 → 8 (-2)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
8
Holders Change
-2
Holders Change %
-20%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ROSG Hedge Fund Activity: Q1 2018 in Review

8 of the 4,376 institutional investors tracked by Wall St. Rank reported a position in Rosetta Genomics (ROSG) for Q1 2018, worth a combined $552K — up 97% from $280K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ROSG and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.

The largest buyer was Sabby Management, opening a new position worth an estimated $453K. The largest seller was Virtu Financial, exiting entirely with an estimated $43K sold.

  • 8 institutional investors held Rosetta Genomics (ROSG) as of Q1 2018, down from 10 in Q4 2017.
  • Funds reported $552K of Rosetta Genomics stock for Q1 2018, up 97% quarter-over-quarter.
  • 1 fund opened new Rosetta Genomics positions in Q1 2018 and 2 closed out, a net change of -1 holder.
  • The largest Rosetta Genomics buyer in Q1 2018 was Sabby Management, an estimated $453K added.
  • The largest Rosetta Genomics seller in Q1 2018 was Virtu Financial, an estimated $43K sold.

Based on aggregated 13F filings for Q1 2018.